Stock CSL CSL LIMITED
Add to a list
To use this feature you must be a member
Log inSign up

Calendar CSL Limited

Equities

CSL

AU000000CSL8

Market Closed - Australian S.E.
Other stock markets
 11:40:45 26/04/2024 am IST 		5-day change 1st Jan Change
273.3 AUD -1.85% Intraday chart for CSL Limited +1.41% -4.66%
26/04 Australian shares tumble as miners, energy stocks fall; BHP Group tanks RE
24/04 CSL Vifor and Travere Therapeutics Announces European Commission Approves FILSPARI® for the Treatment of IgA Nephropathy CI

Chart calendar CSL Limited

c4a00c8bdbeeac2191a3b1e3.dzP2GdPz9jpoZNaq1XX2RWUBdn_gf-1FfPyNM82JihQ.OAqGVLzCvmsxAofwkzCBdF1XL02_GL4EK4jFVo7oxGZGBrtj6r-zSTstkw~ea147ead6ba646d3df488f25865dea30

Upcoming events on CSL Limited

13/08/2024 Q4 2024 Earnings Release
30/10/2024 Annual General Meeting
12/02/2025 Q2 2025 Earnings Release (Projected)
19/08/2025 Q4 2025 Earnings Release (Projected)
18/02/2026 Q2 2026 Earnings Release (Projected)
18/08/2026 Q4 2026 Earnings Release (Projected)

Past events on CSL Limited

06/04/2024 American College of Cardiology Scientific Meeting
11/03/2024 Ex-dividend day for dividende intermédiaire
13/02/2024 Q2 2024 Earnings Call
13/02/2024 02:54 am Q2 2024 Earnings Release
16/10/2023 03:45 am Capital Markets Day
11/10/2023 04:30 am Annual General Meeting
11/10/2023 IDWeek Conference
11/09/2023 Final dividend
15/08/2023 06:30 am Q4 2023 Earnings Call
15/08/2023 04:00 am Q4 2023 Earnings Release
14/06/2023 Business Update Call
29/05/2023 Shareholders Meeting
25/04/2023 11:20 pm Canadian Immunization Conference
09/03/2023 Ex-dividend day for dividende intermédiaire
24/02/2023 American Academy of Allergy, Asthma & Immunology Meeting
14/02/2023 Interim 2023 Earnings Call
14/02/2023 02:40 am Interim 2023 Earnings Release
03/11/2022 03:30 am R&D Day
17/10/2022 04:30 am Investor Meeting
12/10/2022 04:30 am Annual General Meeting

Past dividends on CSL Limited

11/03/2024 Interim Payment 1.798942 AUD
11/09/2023 Final Payment 1.8070038 AUD
11/09/2023 Final Payment 0.2007782 AUD
09/03/2023 Interim Payment 1.621458 AUD
06/09/2022 Final Payment 0.1758307 AUD
06/09/2022 Final Payment 1.5824763 AUD
07/03/2022 Interim Payment 1.422903 AUD
02/09/2021 Final Payment 1.4306886 AUD
02/09/2021 Final Payment 0.1589654 AUD
04/03/2021 Interim Payment 1.349073 AUD

Annual results

Fiscal PeriodJuni 2019 2020 2021 2022 2023 2024
Net sales
Million USD		Released
Forecast
Spread 		8 539
8 493
0.53%		9 151
9 224
-0.79%		10 310
10 095
2.13%		10 562
10 722
-1.49%		13 310
13 344
-0.25%
14 723

EBITDA
Million USD		Released
Forecast
Spread 		2 879
2 911
-1.07%		3 136
3 204
-2.11%		3 720
3 589
3.64%		3 596
3 498
2.8%		3 900
4 259
-8.43%
4 907

EBIT
Million USD		Released
Forecast
Spread 		2 504
2 575
-2.76%		2 717
2 781
-2.33%		3 130
3 104
0.85%		2 927
2 946
-0.64%		3 069
3 546
-13.45%
4 222

Earnings before Tax (EBT)
Million USD		Released
Forecast
Spread 		2 341
2 420
-3.27%		2 573
2 651
-2.97%		2 963
3 000
-1.22%		2 780
2 782
-0.1%		2 663
3 050
-12.68%
3 621

Net income
Million USD		Released
Forecast
Spread 		1 919
1 908
0.57%		2 103
2 115
-0.61%		2 375
2 321
2.34%		2 255
2 255
-0.03%		2 194
2 258
-2.85%
2 712

EPS
USD		Released
Forecast
Spread 		4,23
4,21
0.43%		4,62
4,65
-0.84%		5,21
5,09
2.28%		4,80
4,79
0.25%		4,53
4,65
-2.65%
5,66

Announcement Date13/08/1918/08/2017/08/2116/08/2214/08/23-

Quarterly results

Fiscal PeriodJune 2020 S1 2020 S2 2021 S1 2021 S2 2022 S1 2022 S2 2023 S1 2023 S2 2024 S1 2024 S2
Net sales
Million USD		Released
Forecast
Spread 		4 911
4 821
1.87%		4 240
4 347
-2.45%		5 739
5 569
3.04%		4 571
4 366
4.7%		6 041
5 879
2.76%		4 521
4 682
-3.44%		7 184
7 250
-0.91%		6 127
6 134
-0.13%		8 053
8 016
0.46%
6 657

EBITDA
Million USD		Released
Forecast
Spread 		1 836
1 896
-3.14%		1 300
1 281
1.48%		2 638
2 148
22.83%		1 081
922
17.25%		2 479
2 342
5.87%		1 117
1 048
6.53%		2 516
2 386
5.44%		1 384
1 545
-10.4%		3 042
3 082
-1.3%
2 146

EBIT
Million USD		Released
Forecast
Spread 		1 632
1 689
-3.38%		1 085
1 079
0.51%		2 358
1 923
22.62%		772
730
5.69%		2 215
2 006
10.4%		713
781
-8.78%		2 134
2 233
-4.44%		935
1 249
-25.18%		2 795
2 751
1.59%
1 551

Earnings before Tax (EBT)
Million USD		Released
Forecast
Spread 		1 561
1 611
-3.09%		1 011
1 007
0.44%		2 251
1 843
22.14%		712
746
-4.54%		2 145
1 979
8.39%		635
651
-2.35%		1 963





2 379
2 778
-14.36%


Net income
Million USD		Released
Forecast
Spread 		1 248
1 296
-3.7%		855
805
6.15%		1 810
1 447
25.09%		565
508
11.15%		1 760
1 523
15.59%		494
521
-5.11%		1 623
1 478
9.8%		571
517
10.37%		1 901
1 889
0.61%
782

EPS
USD		Released
Forecast
Spread 		2,74
2,89
-5.19%		1,88
1,93
-2.85%		3,98
3,17
25.55%		1,23
1,22
1.23%		3,85
3,29
17.14%		0,96
1,09
-12.19%		3,37
3,26
3.37%


3,92
4,04
-2.85%


Announcement Date11/02/2018/08/2017/02/2117/08/2115/02/2216/08/2213/02/2314/08/2312/02/24-

Upcoming sector events for CSL Limited

29/04/2024 HEBEI CHANGSHAN BIOCHEMICAL PHARMACEUTICAL CO., LTD.: Q1 2024 Earnings Release
29/04/2024 SHANGHAI OPM BIOSCIENCES CO., LTD.: Q4 2023 Earnings Release
29/04/2024 CANSINO BIOLOGICS INC.: Q1 2024 Earnings Release
29/04/2024 SHANGHAI JUNSHI BIOSCIENCES CO., LTD.: Q1 2024 Earnings Release
29/04/2024 SINOVAC BIOTECH LTD.: Q4 2023 Earnings Release (Projected)
30/04/2024 SHANGHAI RAAS BLOOD PRODUCTS CO., LTD.: Q1 2024 Earnings Release
30/04/2024 SHANDONG SINOBIOWAY BIOMEDICINE CO., LTD.: Q4 2023 Earnings Release
30/04/2024 SHANDONG SINOBIOWAY BIOMEDICINE CO., LTD.: Q1 2024 Earnings Release
30/04/2024 BLOOMAGE BIOTECHNOLOGY CORPORATION LIMITED: Q4 2023 Earnings Release
30/04/2024 04:30 pm INCYTE CORPORATION: Q1 2024 Earnings Release
More events

Past sector events for CSL Limited

Today PACIFIC SHUANGLIN BIO-PHARMACY CO., LTD: Q4 2023 Earnings Release
Today BEIJING BOHUI INNOVATION BIOTECHNOLOGY GROUP CO., LTD.: Q1 2024 Earnings Release
Today SHENZHEN KANGTAI BIOLOGICAL PRODUCTS CO., LTD.: Q1 2024 Earnings Release
Today PACIFIC SHUANGLIN BIO-PHARMACY CO., LTD: Q1 2024 Earnings Release
Today TONGHUA DONGBAO PHARMACEUTICAL CO., LTD.: Q1 2024 Earnings Release
26/04/2024 SHENZHEN WEIGUANG BIOLOGICAL PRODUCTS CO., LTD.: Q1 2024 Earnings Release
26/04/2024 SHANGHAI OPM BIOSCIENCES CO., LTD.: Q1 2024 Earnings Release (Projected)
26/04/2024 LIAONING CHENGDA BIOTECHNOLOGY CO.,LTD.: Q1 2024 Earnings Release (Projected)
26/04/2024 HUALAN BIOLOGICAL VACCINE INC.: Q1 2024 Earnings Release
26/04/2024 HUALAN BIOLOGICAL ENGINEERING INC.: Q1 2024 Earnings Release

Net sales - Quarter - Rate of surprise

Quarterly earnings - Rate of surprise

Net sales - Annual - Rate of surprise

Annual profits - Rate of surprise

  1. Stock Market
  2. Equities
  3. CSL Stock
  4. Calendar CSL Limited